Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · Real-Time Price · USD
1.590
-0.030 (-1.85%)
Nov 21, 2024, 1:27 PM EST - Market open
Biora Therapeutics Stock Forecast
BIOR's stock price has decreased by -87.91% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Biora Therapeutics stock has a target of 23, which predicts an increase of 1,346.54% from the current stock price of 1.59.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for BIOR is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $23 | Strong Buy | Maintains | $15 → $23 | +1,346.54% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +9,333.96% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +9,333.96% | Jul 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +9,333.96% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $500 | Strong Buy | Reiterates | $500 | +31,346.54% | Jan 2, 2024 |
Financial Forecast
Revenue This Year
1.31M
from 4.00K
Increased by 32,550.00%
Revenue Next Year
2.55M
from 1.31M
Increased by 95.48%
EPS This Year
-9.03
from -78.69
EPS Next Year
-11.83
from -9.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.8M | 5.3M | 5.8M |
| Avg | 1.3M | 2.6M | 2.8M |
| Low | 842,800 | 4,900 | 24,500 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 44,525.0% | 302.0% | 126.2% |
| Avg | 32,550.0% | 95.5% | 10.4% |
| Low | 20,970.0% | -99.6% | -99.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -8.82 | -9.98 | -9.98 |
| Avg | -9.03 | -11.83 | -10.81 |
| Low | -9.11 | -13.43 | -11.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.